A Crispy Odyssey to the TNBC Cells
Triple-Negative Breast Cancer (TNBC) cells represent one of the most challenging frontiers in oncology. Unlike other breast cancers, they lack estrogen, progesterone, and HER2 receptors, leaving few conventional treatment options. This absence makes TNBC an elusive adversary, aggressive in growth and prone to recurrence. The scientific odyssey into TNBC cells is “crispy” — sharp, urgent, and full of unexpected turns. Researchers are mapping genetic mutations, unraveling signaling pathways, and testing new therapies like immunotherapy, PARP inhibitors, and targeted drugs. Each discovery is a step deeper into this biological labyrinth, bringing us closer to cracking the code of TNBC and offering hope for more effective treatments.